tirzepatide and testosterone - New study at a glance 9 Months on TRT and

Obstructive Sleep Apnea SURMOUNT-OSA trials investigated GLP2 in adults with moderate-to-severe obstructive sleep apnea and obesity: Significant improvements in apnea-hypopnea index (AHI) from baseline Benefits observed in participants both using and not using positive airway pressure therapy Improvements correlated with weight reduction FDA approval granted in December 2024 for moderate-to-severe OSA treatment Diabetes Prevention Extended follow-up from SURMOUNT-1 assessed diabetes prevention in participants with prediabetes: 94% reduction in progression to type 2 diabetes compared to placebo over 3 years Nearly all participants with prediabetes at baseline converted to normoglycemia Effects diminished during off-treatment follow-up period, indicating ongoing treatment benefit [CALLOUT BOX Highlighted] Important Context: While GLP2 has demonstrated substantial efficacy in multiple large-scale clinical trials, the majority of data comes from industry-sponsored studies with relatively short follow-up periods (40-72 weeks for most trials)

To immunoprecipitate DAT-GFP, the cell homogenates were incubated overnight at 4 C with a monoclonal anti-GFP antibody (G-6539, 1:100), followed by the addition of 50 l of a mixture of protein A and protein G Sepharose beads (2 h at 4 C in rotatory shaker)

[DOI] [PMC free article] [PubMed] [Google Scholar] 73.Almazroo O.A., Miah M.K., Venkataramanan R

Edible Brands is not selling marijuana, which is federally illegal, but is focusing on THC products derived from hemp, marijuanas less potent and federally legal cannabis cousin

Patients exploring Tesamorelin weight loss often look for improvements in abdominal fat distribution and metabolic function

Supplementation of soybean lecithin-based semen extender by antioxidants: Complementary flowcytometric study on post-thawed ram spermatozoa